U.S. puts drug tariffs on the table, threatening entire supply chains

Open this photo in gallery: An employee checks packaged generic drugs before boxing them on an assembly line at Pharmascience manufacturing facility in Montreal, Que. on Dec. 8, 2022.Christinne Muschi/The Globe and Mail The White House has launched a national-security investigation into the entire pharmaceutical supply chain, which threatens to widen potential tariffs to include billions of dollars of Canadian exports of medical ingredients. On Monday, the U.S. Department of Commerce filed notice that it would examine U.S. imports of pharmaceuticals and pharmaceutical ingredients, one of a few key sectors that are being targeted by the Trump administration's protectionism policies….